Page 155 - Binder2

But when you consider the climate of the biologic industry,
it's something that needs to happen.

Here’s what that looks like in practice:

1. Immunology at the Core of Discovery

In a traditional R&D pipeline, target discovery is led by
molecular biologists, pharmacologists, or computational
modelers. Immunology is often siloed in downstream
functions like toxicology or safety review.

153